- Home
- FULC vs CIA Comparison
FULC vs CIA Comparison
Compare FULC & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- CIA
- Stock Information
- Founded
- FULC 2015
- CIA 1969
- Country
- FULC United States
- CIA United States
- Employees
- FULC N/A
- CIA N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- FULC Health Care
- CIA Finance
- Exchange
- FULC Nasdaq
- CIA Nasdaq
- Market Cap
- FULC 221.5M
- CIA 222.9M
- IPO Year
- FULC 2019
- CIA N/A
- Fundamental
- Price
- FULC $3.25
- CIA $5.00
- Analyst Decision
- FULC Hold
- CIA
- Analyst Count
- FULC 10
- CIA 0
- Target Price
- FULC $7.44
- CIA N/A
- AVG Volume (30 Days)
- FULC 843.4K
- CIA 94.5K
- Earning Date
- FULC 11-13-2024
- CIA 11-07-2024
- Dividend Yield
- FULC N/A
- CIA N/A
- EPS Growth
- FULC N/A
- CIA N/A
- EPS
- FULC N/A
- CIA 0.43
- Revenue
- FULC $80,871,000.00
- CIA $248,376,000.00
- Revenue This Year
- FULC $2,821.96
- CIA N/A
- Revenue Next Year
- FULC N/A
- CIA $4.17
- P/E Ratio
- FULC N/A
- CIA $11.56
- Revenue Growth
- FULC 2987.86
- CIA 3.02
- 52 Week Low
- FULC $2.86
- CIA $1.78
- 52 Week High
- FULC $13.70
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- FULC 44.64
- CIA 59.18
- Support Level
- FULC $2.86
- CIA $4.34
- Resistance Level
- FULC $3.94
- CIA $4.85
- Average True Range (ATR)
- FULC 0.23
- CIA 0.25
- MACD
- FULC 0.02
- CIA -0.01
- Stochastic Oscillator
- FULC 36.11
- CIA 71.29
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.